| Common Stock, Shares Authorized |
750,000,000 |
shares |
0% |
Q2 2023 |
Q3 2023 |
| Common Stock, Shares, Issued |
63,593,986 |
shares |
+859.7% |
Q2 2023 |
Q3 2023 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2023 |
Q3 2023 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
2,953 |
USD |
+22.6% |
Q2 2023 |
Q3 2023 |
| Deferred Tax Assets, Valuation Allowance |
429,047 |
USD |
+1.3% |
Q1 2023 |
Q2 2023 |
| Deferred Tax Assets, Operating Loss Carryforwards |
2,073,083 |
USD |
+1.3% |
Q1 2023 |
Q2 2023 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q2 2023 |
Q3 2023 |
| Preferred Stock, Shares Authorized |
125,000,000 |
shares |
|
Q2 2023 |
Q3 2023 |
| Additional Paid in Capital |
1,805,379 |
USD |
+36.6% |
Q2 2023 |
Q3 2023 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q2 2023 |
Q3 2023 |
| Deferred Tax Assets, Net of Valuation Allowance |
429,047 |
USD |
+1.3% |
Q1 2023 |
Q2 2023 |
| Interest Expense |
5,000 |
USD |
|
Q1 2023 |
Q2 2023 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
|
Q2 2023 |
Q3 2023 |